Alterations of cortical thickness and gray‐white matter contrast in Alzheimer's disease and Lewy body‐related cognitive impairment: Human neuropathology/topography of pathology. (7th December 2020)

• Record Type: Journal Article
• Authors: Jeon, Seun; Kim, Hosung; Ye, Byoung Seok; Evans, Alan C.
• Is Part Of: Alzheimer's & dementia. Volume 16(2020)Supplement 2
• Page Start: n/a
• Page End: n/a
• Publication Date: 2020-12-07
• Subjects: Alzheimer's disease -- Periodicals; Alzheimer Disease -- Periodicals; Dementia -- Periodicals; Démence; Maladie d'Alzheimer; Périodique électronique (Descripteur de forme); Ressource Internet (Descripteur de forme); 616.83
• DOI: 10.1002/alz.041245
• Languages: English
• ISSNs: 1552-5260

Abstract

Abstract: Background: Gray and white matter alteration has been known in patients with neurodegenerative diseases including Alzheimer's disease‐ (ADCI) and Lewy body‐related cognitive impairment (LBCI). We examined a distinct pattern of cortical thickness (CTH) and gray‐white matter contrast (GWC) alterations in these degenerative neurological diseases. Since the T1‐weighted MRI signal is closely related to myelin content, the GWC may reflect disease‐related alterations of myeloarchitecture along the cortical surface. Methods: T1‐weighted MRIs were obtained from patients (demo‐matched, CDR‐SOB≤9) with ADCI (n=97), LBCI (n=93), and healthy controls (n=37). We measured CTH using the CIVET processing pipeline. GWC was calculated at each vertex as the difference between gray matter (sampled at 50% CTH) and white matter intensity (sampled at 1mm subcortical white matter), then this was normalized by their average. Group differences (controls vs. patients) and correlations (with neuropsychological scores) were examined using general linear models covarying for age, sex, education, intracranial volume, and several vascular risk factors. Results were corrected for multiple comparisons using random field theory p<0.05 (cluster‐forming threshold p=0.001). Results: Patients with ADCI showed altered CTH in the brain regions typically affected in AD including the bilateral medial temporal, lateral temporo‐parietal, and posterior cingulate cortices. The pattern of GWC alteration was smaller and no change was shown in the lateral temporal lobe (Figure 1A). LBCI patients showed altered CTH in superior frontal, lateral temporal, basal frontal and occipital cortices. The GWC alteration pattern was shown in larger area, notably in the limbic and occipital cortices (Figure 1B). Memory function, in the AD‐spectrum, was more closely associated with CTH, while in the LB‐spectrum, it was more closely with GWC (Figure 2). Frontal/executive function has stronger association with CTH than with GWC in the AD‐spectrum, while the LB‐spectrum showed independent patterns of association in those measures (Figure 3). The visuospatial function was only associated with CTH in AD‐spectrum, and in LB‐spectrum, it was greater in CTH than in GWC (Figure 4). Conclusions: We demonstrated distinct patterns of CTH and GWC alteration in ADCI and LBCI. Consideration of heterogeneous atrophy patterns may be important when planning prevention and treatment strategies, as they may have different responses to treatment in the disease progression.